What happens when cell analysis moves beyond simply measuring more to understanding more?
In the latest episode of PharmaShots CXO Talks, Wenbin Jiang, CEO and Chairman of the Board, and William McCombe, Chief Financial Officer, Cytek Biosciences, explore how advances in flow cytometry, AI, imaging, and cloud-based analytics are reshaping the way researchers understand cells.…
Shots:
PharmaShots’ May Edition explores how AI is transforming commercial strategies across the healthcare ecosystem by enabling predictive analytics, personalized engagement, dynamic launch planning, and real-time omnichannel optimization while balancing compliance and measurable ROI.
The magazine highlights key industry movements shaping global biopharma, including AI-driven drug discovery collaborations, strategic M&A activity, advancements in cell and…
Shots:
AI is redefining visibility in pharma as it becomes the primary gateway to information, requiring companies to shift from content publishing to engineering discoverability with machine-readable, well-cited, and rapidly updated data to be included in AI-generated summaries
Integrated, structured evidence is now critical for success in AI-driven environments, demanding modular, metadata-rich, and consistent data…

